Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Marek Minarik · SciRah

Researcher profile · Semantic Scholar

Marek Minarik

Share profile

Marek Minarik — researcher profile on SciRah

h-index: 23
Works: 114
Citations: 1,516

Most-cited papers

Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
L. Benesova, B. Belšánová, S. Suchanek, M. Kopečková +6 more
2013Analytical Biochemistry104 citations
Semantic Scholar
Colorectal cancer screening: 20 years of development and recent progress.
M. Zavoral, S. Suchanek, O. Májek, P. Frič +4 more
2014World Journal of Gastroenterology76 citations Open access
Semantic Scholar
Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors.
L. Benesova, Marek Minarik, D. Jancarikova, B. Belšánová +1 more
2010Anticancer Research61 citations
Semantic Scholar
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.
O. Fiala, M. Pesek, J. Finek, J. Rácek +6 more
2016Neoplasma (Bratislava)60 citations Open access
Semantic Scholar
The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
O. Fiala, M. Pesek, J. Finek, L. Benesova +2 more
2013Cancer Genetics59 citations
Semantic Scholar
Molecular biology of pancreatic cancer.
M. Zavoral, P. Mináriková, F. Závada, C. Šálek +1 more
2011World Journal of Gastroenterology53 citations Open access
Semantic Scholar
Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.
O. Fiala, M. Pesek, J. Finek, L. Benesova +3 more
2014Anticancer Research45 citations
Semantic Scholar
Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
M. Pesek, L. Benesova, B. Belšánová, P. Mukeňsnabl +2 more
2009Anticancer Research42 citations
Semantic Scholar
Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening
S. Suchanek, O. Májek, G. Vojtechova, P. Mináriková +6 more
2014European Journal of Cancer Prevention39 citations Open access
Semantic Scholar
MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis
T. Halkova, Romana Čuperková, Marek Minarik, L. Benesova
2015Gastroenterology Research and Practice38 citations Open access
Semantic Scholar
Somatic TP53 mutation mosaicism in a patient with Li–Fraumeni syndrome
Kamila Prochazkova, K. Pavlíková, Marek Minarik, D. Sumerauer +2 more
2009American Journal of Medical Genetics. Part A38 citations
Semantic Scholar
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
O. Fiala, M. Pesek, J. Finek, Marek Minarik +3 more
2015Tumor Biology37 citations
Semantic Scholar
Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
C. Šálek, P. Mináriková, L. Benesova, V. Nosek +3 more
2009Anticancer Research36 citations
Semantic Scholar
Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacy.
O. Fiala, M. Pesek, J. Finek, L. Benesova +2 more
2013Anticancer Research34 citations
Semantic Scholar
The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy.
M. Svaton, O. Fiala, M. Pesek, Z. Bortlíček +3 more
2016Anticancer Research33 citations
Semantic Scholar
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
L. Benesova, T. Halkova, R. Ptackova, A. Semyakina +9 more
2019World Journal of Gastroenterology30 citations Open access
Semantic Scholar
Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.
M. Svaton, O. Fiala, M. Pesek, F. Bruha +4 more
2014Anticancer Research30 citations
Semantic Scholar
Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy
K. Čurila, L. Benesova, M. Penicka, Marek Minarik +4 more
2012Acta Cardiologica30 citations
Semantic Scholar
Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease.
M. Pesek, M. Kopečková, L. Benesova, A. Mészárosová +3 more
2011Anticancer Research28 citations
Semantic Scholar
Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructure.
Jan Zastera, L. Roewer, Sascha Willuweit, P. Sekerka +2 more
2010Forensic Science International: Genetics28 citations
Semantic Scholar
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.
O. Fiala, M. Pesek, J. Finek, O. Topolcan +9 more
2016Anticancer Research22 citations
Semantic Scholar
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib
O. Fiala, M. Pesek, J. Finek, O. Topolcan +6 more
2015Tumor Biology22 citations
Semantic Scholar
Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice.
O. Fiala, M. Pesek, J. Finek, J. Krejci +4 more
2012Neoplasma (Bratislava)22 citations Open access
Semantic Scholar
Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study
O. Fiala, J. Baxa, M. Svaton, L. Benesova +8 more
2022Cancer Genomics & Proteomics19 citations Open access
Semantic Scholar
Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients.
M. Levý, L. Benesova, L. Lipská, B. Belšánová +4 more
2012Anticancer Research19 citations
Semantic Scholar
The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected].
O. Fiala, M. Pesek, J. Finek, L. Benesova +3 more
2014Anticancer Research17 citations
Semantic Scholar
Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.
O. Fiala, P. Hošek, M. Pesek, J. Finek +9 more
2017Anticancer Research15 citations Open access
Semantic Scholar
Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.
O. Fiala, M. Pesek, J. Finek, Marek Minarik +6 more
2016Anticancer Research14 citations
Semantic Scholar
Low Prevalence and Variable Clinical Presentation of Troponin I and Troponin T Gene Mutations in Hypertrophic Cardiomyopathy
K. Čurila, L. Benesova, M. Penicka, Marek Minarik +4 more
2009Genetic Testing and Molecular Biomarkers14 citations
Semantic Scholar
Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC.
O. Fiala, M. Pesek, J. Finek, L. Benesova +2 more
2013Neoplasma (Bratislava)13 citations Open access
Semantic Scholar
Sequential treatment of advanced-stage lung adenocarcinoma harboring wild-type EGFR gene: second-line pemetrexed followed by third-line erlotinib versus the reverse sequence.
O. Fiala, M. Pesek, J. Finek, L. Benesova +2 more
2013Anticancer Research13 citations
Semantic Scholar
Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery.
G. Vojtechova, L. Benesova, B. Belšánová, P. Mináriková +5 more
2016Advances in Clinical and Experimental Medicine11 citations Open access
Semantic Scholar
A novel high‐resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA
Marek Minarik, Marcus Gassman, B. Belšánová, M. Pesek +4 more
2010Electrophoresis11 citations
Semantic Scholar
Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
P. Mináriková, L. Benesova, T. Halkova, B. Belšánová +5 more
2016Gastroenterology Research and Practice10 citations Open access
Semantic Scholar
Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on‐chip capillary electrophoresis
Marek Minarik, M. Kopečková, Marcus Gassman, P. Osmančík +1 more
2012Electrophoresis10 citations
Semantic Scholar
Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC
M. Burešová, L. Benesova, Marek Minarik, R. Ptackova +6 more
2023Journal of Cancer9 citations Open access
Semantic Scholar
IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas.
F. Kramar, Marek Minarik, L. Benesova, T. Halkova +3 more
2016Folia biologica9 citations Open access
Semantic Scholar
Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease
P. Paulů, P. Osmančík, P. Toušek, Marek Minarik +5 more
2013Journal of Thrombosis and Thrombolysis9 citations
Semantic Scholar
[EGFR mutations in patients with advanced NSCLC].
O. Fiala, M. Pesek, J. Finek, F. Bruha +4 more
2012Klinicka onkologie9 citations
Semantic Scholar
Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.
P. Tomašov, Marek Minarik, D. Zemánek, P. Čadová +7 more
2014Folia biologica8 citations Open access
Semantic Scholar
Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapy.
O. Fiala, M. Pesek, J. Finek, J. Krejci +3 more
2013Neoplasma (Bratislava)8 citations Open access
Semantic Scholar
Capillary electrophoresis, a method for the determination of nucleic acid ligands covalently attached to quantum dots representing a donor of Förster resonance energy transfer.
V. Datinská, K. Klepárník, B. Belšánová, Marek Minarik +1 more
2018Journal of Separation Science7 citations
Semantic Scholar
Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer
L. Benesova, T. Halkova, B. Bunganič, B. Belšánová +3 more
2018Pathology and Oncology Research7 citations
Semantic Scholar
Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.
P. Mináriková, L. Benesova, T. Halkova, B. Belšánová +6 more
2016World Journal of Gastroenterology7 citations Open access
Semantic Scholar
The new “global”: the role of cargo maritime transport of goods with focus on the transportation corridor between Southeast Asia and Northwestern Europe
Marek Minarik, Denisa Čiderová
2021SHS Web of Conferences6 citations Open access
Semantic Scholar
High performance liquid chromatography column efficiency enhancement by zero dead volume recycling and practical approach using park and recycle arrangement.
Marek Minarik, M. Franc, M. Minarik
2018Journal of Chromatography A6 citations
Semantic Scholar
Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy
K. Čurila, L. Benesova, P. Tomašov, B. Belšánová +5 more
2015The Cardiology6 citations
Semantic Scholar
Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumors.
L. Benesova, B. Belšánová, F. Kramar, T. Halkova +2 more
2018Journal of Separation Science5 citations
Semantic Scholar
Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy.
L. Benesova, M. Pesek, B. Belšánová, P. Sekerka +1 more
2010Journal of Separation Science5 citations
Semantic Scholar
Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.
O. Fiala, M. Pesek, J. Finek, M. Svaton +5 more
2016Anticancer Research4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Benesova×42
Invite
L. Benesova — researcher profile on SciRah
M. Pesek×25
Invite
M. Pesek — researcher profile on SciRah
O. Fiala×20
Invite
O. Fiala — researcher profile on SciRah
J. Finek×17
Invite
J. Finek — researcher profile on SciRah

B. Belšánová

×15

Invite

B. Belšánová — researcher profile on SciRah

Invite

M. Zavoral — researcher profile on SciRah

O. Topolcan×10

Invite

O. Topolcan — researcher profile on SciRah

Z. Bortlíček×10

Invite

Z. Bortlíček — researcher profile on SciRah

P. Mináriková×9

Invite

P. Mináriková — researcher profile on SciRah

Invite

T. Halkova — researcher profile on SciRah

Invite

M. Svaton — researcher profile on SciRah

Z. Bortlíček×6

Invite

Z. Bortlíček — researcher profile on SciRah